View Post

Researchers identify potential target for new breast cancer treatments

In In The News by Barbara Jacoby

Source: https://www.kcl.ac.uk From: news-medical.net Researchers from the School of Basic & Medical Biosciences have identified a potential target that could lead to new treatments for triple negative breast cancer. One in five patients with breast cancer are diagnosed with triple negative breast cancer, a cancer type where tumour cells don’t have receptors for oestrogen and progesterone, or the Her2 protein. …

View Post

CytRx Corporation Highlights Aldoxorubicin Included in New NantCell Inc. Triple Negative Breast Cancer Clinical Trial

In Clinical Trials by Barbara Jacoby

News provided by: CytRx Corporation From: prnewswire.com This New Trial Represents the Third NantCell Study Evaluating Aldoxorubicin Combined with Immunotherapy or Cell-Based Therapy CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today highlighted that aldoxorubicin licensee NantCell, Inc., a private subsidiary of NantWorks, LLC, has dosed the first patient in the Phase 1b portion of a …

View Post

CAR-T Trial for Triple-Negative Breast Cancer Under Way

In Clinical Trials by Barbara Jacoby

By: Christina Bennett, MS From: cancertherapyadvisor.com A phase 1 trial (ClinicalTrials.gov Identifier: NCT02706392) is underway at Fred Hutchinson Cancer Research Center to evaluate a chimeric antigen receptor (CAR) T cell therapy in patients with cancer who have receptor tyrosine kinase-like orphan receptor 1 (ROR1)-positive disease, including those with triple-negative breast cancer (TNBC). The trial progress and early data for patients …

View Post

New Clinical Trial for Triple-Negative Breast Cancer at Sylvester Comprehensive Cancer Center

In Clinical Trials by Barbara Jacoby

Vaccine Designed to Prevent Recurrence Panic washed over Jackie Barrett when she first received her breast cancer diagnosis. “My eyes went dark. I couldn’t hear anything. It was like a train was coming at me,” she says. Jackie’s oncologist explained that her type of breast cancer is called triple-negative because it does not have receptors for estrogen, progesterone or the …

View Post

Norwalk Hospital reports positive results with breast cancer clinical trials

In Clinical Trials by Barbara Jacoby

By: Kevin Zimmerman From: westfaironline.com Four cutting-edge breast cancer clinical trials recently launched at Norwalk Hospital’s C. Anthony and Jean Whittingham Cancer Center are giving hope to patients diagnosed with triple negative breast cancer, an aggressive form of the disease that cannot be treated with hormone therapies or other cancer-fighting drugs. “We started about six months ago,” said Dr. Linda …

View Post

Immunotherapy trial offers new hope for people with aggressive breast cancer

In Clinical Trials by Barbara Jacoby

Source: qmul.ac.uk From: news-medical.net There is new hope for people with an aggressive type of breast cancer, as an immunotherapy trial shows for the first time that lives can be extended in people with triple-negative breast cancer. New research led by Queen Mary University of London and St Bartholomew’s Hospital has shown that by using a combination of immunotherapy and …

View Post

Existing drug may treat triple-negative breast cancer

In In The News, Uncategorized by Barbara Jacoby

By: Ana Sandoiu From: medicalnewstoday.com The existing drug estradiol can inhibit tumor growth in a subtype of triple-negative breast cancer. The researchers may soon test the repurposed drug in a phase II clinical trial. Triple-negative breast cancer is an aggressive form of breast cancer wherein tumors lack expression of three proteins. The three are estrogen receptor, progesterone receptor, and human …

Western Connecticut Health Network Site Launches Breast Cancer Clinical Trials through Collaboration with Memorial Sloan Kettering Cancer Center

In Clinical Trials by Barbara Jacoby

As part of a pioneering cancer-care collaboration between Norwalk Hospital and Memorial Sloan Kettering Cancer Center, clinical trials studying new breast cancer therapies are now open in Fairfield County. Four cutting-edge breast cancer clinical trials have launched at Norwalk Hospital, part of the Western Connecticut Health Network. The breast cancer clinical trials are an extension of Memorial Sloan Kettering Cancer …